Ali Behbahani

Companies

• SpyGlass Pharma, Inc.Board member Feb 5, 2026 to now¹
• Bright HealthBoard member Oct 6, 2025 to now²
• Korro Bio, Inc.Board member Nov 7, 2023 to now³
• Arcellx, Inc.Board member Feb 3, 2022 to now⁴
• Monte Rosa TherapeuticsBoard member Jun 23, 2021 to now⁵
• Nkarta Therapeutics (United States)Board member Jul 9, 2020 to now⁶
• Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to now⁷
• CRISPR TherapeuticsBoard member Oct 18, 2016 to now⁸
• Adaptimmune (United Kingdom)Board member Jan 4, 2016 to now⁹
• CVRx (United States)Board member Jun 29, 2021 to Jun 7, 2024¹⁰
• Oyster Point Pharma, Inc.Board member Oct 30, 2019 to Jan 4, 2023¹¹
• MINERVA SURGICAL INCBoard member Oct 21, 2021 to Jun 14, 2022¹²
• Genocea (United States)Board member Feb 12, 2018 to May 26, 2022¹³
• Marker Therapeutics, Inc.Board member Oct 18, 2018 to Oct 18, 2018¹⁴
• NEVRO CORPBoard member Nov 5, 2014 to May 23, 2018¹⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSpyGlass Pharma, Inc. SGP1,357,263 shares¹⁶$33.6M at $24.78Feb 9, 2026
• KBKorro Bio, Inc. KRRO1,297,893 shares¹⁷$12.1M at $9.31Mar 10, 2026
• BDBlack Diamond Therapeutics, Inc. BDTX4,558,993 shares¹⁸$7.8M at $1.72Sep 21, 2026
• CRISPR Therapeutics CRSP16,666 shares¹⁹$820.8K at $49.25Sep 21, 2026
• CUCVRx (United States) CVRX316 shares²⁰$411 at $1.30Dec 14, 2023
• MSMINERVA SURGICAL INC58,279 shares²¹Jun 10, 2022
• GUGenocea (United States)0 shares²²May 25, 2022
• AUAdaptimmune (United Kingdom) ADAPY0 shares²³Aug 18, 2025
• Bright Health BHG0 shares²⁴Oct 2, 2025
• OPOyster Point Pharma, Inc.0 shares²⁵Jan 3, 2023
• AArcellx, Inc.0 shares²⁶Apr 28, 2026
• MRMonte Rosa Therapeutics GLUE0 shares²⁷Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 18, 2026Granted 7,707 shares at $1.93 of Black Diamond Therapeutics, Inc.¹⁸
• Sep 17, 2026Sold 13,679 shares at $57.09 of CRISPR Therapeutics¹⁹
• Sep 17, 2026Exercised options 30,000 shares at $14.00 of CRISPR Therapeutics¹⁹
• Jul 1, 2026Other 15,000 shares of Monte Rosa Therapeutics²⁷
• Jul 1, 2026Other 15,000 shares of Monte Rosa Therapeutics²⁷
• Jul 1, 2026Other 1,000,000 shares of Monte Rosa Therapeutics²⁷
• Jun 19, 2026Granted 8,961 shares at $1.66 of Black Diamond Therapeutics, Inc.²⁸
• Apr 28, 2026U 2,706 shares of Arcellx, Inc.²⁶
• Apr 28, 2026U 1,925 shares of Arcellx, Inc.²⁶
• Mar 20, 2026Granted 6,919 shares at $2.15 of Black Diamond Therapeutics, Inc.²⁹
• Mar 10, 2026Granted 207,100 shares at $11.11 of Korro Bio, Inc.¹⁷
• Feb 9, 2026Converted 402,273 shares of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Converted 954,990 shares of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Bought 937,500 shares at $16.00 of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Converted 737,962 shares of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Converted 1,370,168 shares of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Converted 1,370,168 shares of SpyGlass Pharma, Inc.¹⁶
• Feb 9, 2026Converted 1,619,240 shares of SpyGlass Pharma, Inc.¹⁶
• Dec 12, 2025Granted 5,208 shares at $2.76 of Black Diamond Therapeutics, Inc.³⁰
• Oct 2, 2025Returned to company 2,384,873 shares of Bright Health²⁴
• Oct 2, 2025Shares withheld for tax 182 shares at $6.75 of Bright Health²⁴
• Oct 2, 2025Exercised options 124,085 shares at $0.01 of Bright Health²⁴
• Oct 2, 2025Sold 900 shares at $6.75 of Bright Health²⁴
• Oct 2, 2025Exercised 607,536 shares at $0.01 of Bright Health²⁴
• Oct 2, 2025Sold 2,455 shares at $6.75 of Bright Health²⁴